Symptoms

Symptoms vary widely because the migrated stent may lodge in a different organ system. Below is a complete list with typical descriptions.

Cardiovascular (coronary, peripheral) stents

• Chest pain or pressure – may feel like angina if the stent moves and re‑narrowing occurs.
• Shortness of breath – due to reduced cardiac output.
• Palpitations or irregular heartbeat.
• Sudden onset of leg pain or claudication – if a peripheral stent migrates and blocks flow to the limb.
• Weakness, dizziness, or fainting – signs of decreased perfusion.

Biliary stents

• Upper abdominal (right upper quadrant) pain – may be sharp or crampy.
• Jaundice – yellowing of skin and eyes if bile flow is blocked again.
• Fever or chills – indicates possible infection (cholangitis).
• Nausea, vomiting, or loss of appetite.
• Dark urine / pale stools – signs of impaired bilirubin excretion.

Ureteral (urinary) stents

• Flank pain or kidney colic – often radiating to the groin.
• Frequent, urgent urination or inability to empty the bladder.
• Hematuria (blood in urine).
• Pelvic or genital discomfort if the stent migrates into the bladder.
• Fever or urinary tract infection symptoms.

Gastrointestinal stents (esophageal, colonic)

• Difficulty swallowing or feeling of food “sticking” (esophageal).
• Abdominal cramping, bloating, or vomiting (colonic).
• Unexplained weight loss.

Causes and Risk Factors

Stent migration is usually multifactorial. Understanding the mechanisms helps both clinicians and patients anticipate risk.

Mechanical Factors

• Improper sizing – a stent that is too short, too small in diameter, or overly flexible can be dislodged by blood flow or peristalsis.
• High‑pressure gradients – vigorous arterial flow or bile/urine pressure can push a stent downstream.
• Excessive vessel or duct tortuosity – bends increase shear forces on the stent.

Biological Factors

• Calcification or extensive atherosclerosis – reduces friction, allowing slippage.
• Inflammation or infection – can degrade tissue surrounding the stent, loosening it.
• Rapid tissue remodeling – especially after tumor shrinkage from chemotherapy, which may “shrink” the space the stent occupies.

Patient‑Related Risk Factors

• Older age (>65 years) – vessel walls become more compliant.
• Chronic kidney disease – alters vascular compliance.
• History of previous stent placement or multiple interventions.
• Use of certain medications (e.g., potent anticoagulants) that may prevent proper endothelialization of the stent.
• Obesity – increased intra‑abdominal pressure can affect biliary and ureteral stents.

Diagnosis

Prompt recognition of stent migration hinges on a detailed history, physical exam, and targeted imaging.

Clinical Assessment

• Ask about recent procedures, type of stent, and timing of symptom onset.
• Physical exam focused on the affected system (cardiac auscultation, abdominal tenderness, flank exam, etc.).

Imaging Studies

• X‑ray (plain radiography) – first‑line for most metallic stents; radiopaque markers make them visible.
• Fluoroscopy – dynamic imaging used during interventional procedures; can confirm exact position.
• CT scan – provides 3‑D localization; especially useful for biliary or ureteral stents that may have migrated into the abdomen or pelvis.
• MR angiography (MRA) or non‑contrast MRI – for patients with contraindications to iodinated contrast.
• Ultrasound – often employed for biliary and ureteral stents; can detect obstruction and secondary dilation (e.g., hydronephrosis).
• Endoscopic evaluation – upper endoscopy or cystoscopy can directly visualize migrated esophageal or urinary stents.

Laboratory Tests

While labs do not diagnose migration, they help assess complications:

• Complete blood count (CBC) – looks for infection or anemia.
• Liver function tests (AST, ALT, ALP, bilirubin) – elevated in biliary obstruction.
• Serum creatinine and eGFR – baseline for patients with renal stents.
• Cardiac enzymes (troponin) – if chest pain suggests myocardial ischemia.

Treatment Options

The therapeutic goal is to retrieve or reposition the stent, relieve obstruction, and prevent recurrence.

Non‑invasive Management

• Observation – Small, asymptomatic migrations (e.g., a coronary stent that has lodged in a distal branch without ischemia) may be monitored with serial imaging, especially in high‑risk surgical candidates.
• Medication – Antiplatelet therapy (aspirin + P2Y12 inhibitor) continues as per the original indication to avoid thrombus formation on a displaced vascular stent.

Endovascular or Endoscopic Retrieval

• Snare devices – Frequently used under fluoroscopic guidance to capture and retrieve a migrated stent from blood vessels, biliary tree, or urinary tract.
• Balloon‑catheter techniques – Inflate a balloon distal to the stent, pull back to bring it into a retrieval sheath.
• Endoscopic graspers – For gastrointestinal or ureteral stents visible via endoscope.

Surgical Options

• Open or laparoscopic surgery – Required when the stent has perforated an organ, caused severe obstruction, or cannot be accessed endovascularly.
• Bypass grafting – Occasionally performed in peripheral arterial migration where the vessel is severely damaged.

Replacement Stent Placement

If the original lesion still requires support, a correctly sized replacement stent is placed after retrieval. Modern drug‑eluting or bio‑resorbable stents may lower future migration risk.

Lifestyle and Supportive Measures

• Continue prescribed antiplatelet or anticoagulant regimens.
• Hydration – especially for ureteral stents, to promote urine flow and reduce discomfort.
• Pain control – acetaminophen or short courses of NSAIDs (if not contraindicated); avoid opioids unless necessary.

Living with Jettisoned Stent (Stent Migration)

Even after successful retrieval or repositioning, patients may have lingering concerns. Below are practical tips for daily life.

Medication Adherence

• Take antiplatelet agents exactly as prescribed (usually one aspirin + one P2Y12 inhibitor for 6–12 months after coronary stenting).
• Report any side effects (e.g., easy bruising, GI upset) to your clinician promptly.

Activity Guidelines

• Cardiovascular stents – Light to moderate activity is safe after 24–48 hours if pain‑free. Avoid heavy lifting (>10 kg) or high‑impact sports for the first 2 weeks, unless cleared.
• Biliary or ureteral stents – No specific restrictions, but avoid prolonged sitting that may increase pressure on the abdomen.

Monitoring Signs

Keep a symptom diary for the first month after an intervention. Note any new or worsening pain, fever, changes in urine or stool color, and palpitations.

Follow‑up Appointments

• First imaging check 4–6 weeks post‑procedure to confirm stent position.
• Routine cardiac stress test or Doppler ultrasound at 6‑month intervals for high‑risk coronary stents.

Psychological Support

Experiencing a stent migration can be anxiety‑provoking. Consider counseling, patient support groups (e.g., American Heart Association community), or mindfulness techniques.

Prevention

Many migration events can be avoided with meticulous planning and patient education.

Optimal Stent Selection

• Choose a stent length and diameter that exceeds the lesion by at least 2–3 mm on each side (as recommended by ACC/AHA guidelines).
• Use “self‑expanding” stents in highly tortuous vessels where flexibility is needed, but verify anchoring mechanisms.

Procedural Techniques

• High‑resolution intravascular imaging (IVUS or OCT) to ensure full lesion coverage before deployment.
• Post‑deployment “post‑dilation” with a balloon to improve wall apposition.
• For biliary and ureteral stents, secure the external loop (for ureteral) or place a “pigtail” distal tip to prevent proximal movement.

Patient‑Centered Measures

• Educate patients on signs of migration before discharge.
• Encourage smoking cessation and blood pressure control—both improve vascular wall integrity.
• Maintain regular follow‑up imaging according to the stent type.

Complications

If a migrated stent is not identified or treated promptly, several serious complications can arise.

• Ischemia or infarction – loss of blood flow to heart muscle, limb, or organ leading to tissue death.
• Perforation – especially with biliary or gastrointestinal stents, causing peritonitis.
• Infection – e.g., cholangitis, urinary tract infection, or sepsis from a foreign body.
• Thrombosis – blood clot formation on a displaced vascular stent, risking stroke or myocardial infarction.
• Obstruction – mechanical blockage of bile ducts or ureters leading to jaundice or hydronephrosis.
• Arterial embolism – a stent traveling to a distal vessel can occlude flow, causing acute limb ischemia.

When to Seek Emergency Care

References

1. American College of Cardiology. 2024 ACC/AHA Guideline for Coronary Artery Revascularization. 2024.
2. Lee J, Kim H, et al. Migration of Biliary Stents: Incidence, Risk Factors, and Management. World J Gastroenterol. 2022;28(31):4572‑4584.
3. Mayo Clinic. “Stent placement: what to expect.” Updated 2023. https://www.mayoclinic.org
4. Cleveland Clinic. “Understanding Stent Migration.” 2023. https://my.clevelandclinic.org
5. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Ureteral Stents.” 2022.